ID-PROSTATE Project

Integrated Diagnostics for Prostate Cancer

About the project

Prostate cancer is the most common type of cancer in men and their second leading cause of death; however, it is highly treatable in the early stages. Recent studies and clinical trials have demonstrated the efficiency of prostate MRI in early diagnosis, with 5 times less missed cancer cases and 25 % fewer biopsies.

Care standards now recommend MRI prior to every biopsy, leading to an increased demand for prostate MRI scans. Conventional radiology reading capacity cannot keep pace with the demand.

At Quantib, we developed an AI-enhanced integrated diagnostic solution for the detection of potential tumors and workflow optimization involving urologists, radiologists and pathologists.The current EU-funded ID-PROSTATE project allows further improvement and acceleration focusing on product commercialization.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 961205. 

 

EU emblem

This project is funded

by the European Union

 

ULTIMATE GUIDE

AI in prostate cancer - homepage image

The Ultimate Guide to AI in Prostate Cancer

How does artificial intelligence work? What are promising AI applications in the prostate cancer pathway? Which solutions are available now?

Read more

VIDEO

P4 Tim

How AI can help with Quantification in Radiology

The benefits of AI for radiology are numerous. Tim Leiner, Professor of Radiology at the Department of Radiology, Utrecht University Medical Center in Utrecht, The Netherlands discusses how AI-powered tools can support the radiologists in their daily clinical workflow

WATCH VIDEO

LATEST POSTS

AI radiology software integration: Node on the cloud vs Node onsite

Oct 5, 2021 5:11:11 PM BY Giulia Chiaruzzi

How can urologists improve patient care in the prostate cancer pathway?

Sep 2, 2021 4:30:00 PM BY Almar van Loon

Subscribe to Updates